Date: 2015-02-24
Type of information: Collaboration agreement
Compound:
Company: Biomed X (Germany) Roche (Switzerland)
Therapeutic area: Technology - Services
Type agreement: collaboration R&D
Action mechanism:
Disease:
Details: * On February 24, 2015, Roche and BioMed X announced that they have entered into a collaboration agreement to establish a research group focusing on the development of a novel sensor technology platform based on new nanomaterials such as graphene. Outstanding early career scientists from leading academic institutions world-wide are invited to submit original project proposals in the fields of biotechnology, nanotechnology and engineering. Roche and BioMed X will jointly select the best ideas and research talents to form a new research group within BioMed X’s open innovation lab in Heidelberg. BioMed X has developed a unique innovation model offering a project plan competition, an attractive funding package, entrepreneurial education and guidance by experienced mentors from academia and industry. BioMed X’s open innovation lab is part of the multi-disciplinary life science campus of the University of Heidelberg which provides an inspiring, interdisciplinary environment for project teams. The unique supportive setting of BioMed X provides an exciting opportunity for the winners of the project plan competition to combine state-of-the-art nanomaterials research with biomedical know-how in order to develop a new sensor technology platform for near-patient testing. BioMed X’s recruitment process allows the partners to select the best research team from among the candidates. BioMed X will be responsible for the operation of the innovation center facility, providing entrepreneurial education and enabling access to the Heidelberg scientific community and research facilities.
Financial terms:
Latest news:
